|
Assessing Antiangiogenic Drugs Preclinically: How Predictive and Clinically Relevant Are the Models?
Moderator: Napoleone Ferrara, Genentech Inc., South San Francisco, CA
- Lee M. Ellis, The University of Texas MD Anderson Cancer Center, Houston, TX
- Robert S. Kerbel, University of Toronto Sunnybrook HSC, Toronto, ON, Canada
Building Effective Research Teams and Collaborations to Address Cancer Health Disparities: The MICR Forum
Chairperson: Chanita Hughes Halbert, University of Pennsylvania, Philadelphia, PA
- Robert T. Croyle, National Cancer Institute, Bethesda, MD
- Li Ding, The Genome Institute at Washington University, St. Louis, MO
- Pebbles Fagan, National Cancer Institute, Bethesda, MD
- Jean G. Ford, Johns Hopkins University, Baltimore, MD
Can siRNA Cure Cancer?
Moderator: Daniel G. Anderson, Massachusetts Institute of Technology, Cambridge, MA
- Jared A. Gollob, Alnylam Pharmaceuticals, Inc., Cambridge, MA
- Mark Kay, Stanford University School of Medicine, Stanford, CA
Circulating Tumor Cells: Enumeration and Molecular Characterization Are Great, But Do They Have Clinical Utility?
Moderator: Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
- Dave S.B. Hoon, John Wayne Cancer Institute, Santa Monica, CA
- Klaus Pantel, University Medical Center Hamburg, Hamburg, Germany
Do Cell Phones Cause Brain Cancer?
Moderator: Jack Siemiatycki, University of Montreal, Montreal, QC, Canada
- Siegal Sadetzki, Chaim Sheba Medical Center, Tel Hashomer, Israel
- Jack Siemiatycki
- Anthony Swerdlow, The Institute of Cancer Research, London, United Kingdom
Envisioning Improved Anticancer Drug Development
Moderator: Johann S. De Bono, Institute of Cancer Research, Sutton, United Kingdom
- Patricia M. LoRusso, Barbara Ann Karmanos Cancer Institute, Detroit, MI
- Timothy A. Yap, Royal Marsden NHS Foundation Trust, London, United Kingdom
Epigenetics or Epiphenomena?
Moderator: Myles Brown, Dana-Farber Cancer Institute, Boston, MA
- Steven Henikoff, Fred Hutchinson Cancer Research Center, Seattle, WA
- Kevin Struhl, Harvard Medical School, Boston, MA
Genomic Signatures and Predictive Biomarkers in Breast Cancer: Challenges and Controversies
Moderator: Jorge Reis-Filho, Institute of Cancer Research, London, United Kingdom
- Lajos Pusztai, The University of Texas MD Anderson Cancer Center, Houston, TX
- Charles Swanton, Cancer Research UK, London, United Kingdom
How Can We Improve the Success Rate for Oncology Drugs?
Moderator: D. Gary Gilliland, Merck & Co. Inc., North Wales, PA
- Sandra J. Horning, Genentech Inc., San Francisco, CA
- Debasish Roychowdhury, Sanofi-Aventis, Cambridge, MA
Intermediate Endpoints for Cancer Prevention Trials: Progress or Paralysis?
Moderator: Scott M. Lippman, The University of Texas MD Anderson Cancer Center, Houston, TX
- Carol J. Fabian, University of Kansas Medical Center, Westwood, KS
- Eva Szabo, National Cancer Institute, Potomac, MD
Is There a Metastatic Niche?
Moderator: Zena Werb, University of California, San Francisco, CA
- Robert J. Coffey Jr., Vanderbilt University Medical Center, Nashville, TN
- Russell Taichman, University of Michigan School of Dentistry, Ann Arbor, MI
Nutrition and Cancer: How Much Does It Really Matter?
Chairperson: John A. Milner, National Cancer Institute, Rockville, MD
Moderator: Peter Greenwald, National Cancer Institute, Rockville, MD
- Elio Riboli, Imperial College London, London, United Kingdom
- Henry J. Thompson, Colorado State University, Fort Collins, CO
Viruses in Cancer Diagnostics and Therapeutics
Moderator: Renata Pasqualini, The University of Texas MD Anderson Cancer Center, Houston, TX
- Wadih Arap, The University of Texas MD Anderson Cancer Center, Houston, TX
- John C. Bell, Ottawa Health Research Institute, Ottawa, ON, Canada
- Bernard Roizman, University of Chicago, Chicago, IL
What Can We Learn About Cancer From Nonmammalian Models?
Moderator: Ross L. Cagan, Mount Sinai School of Medicine, New York, NY
- A. Thomas Look, Dana-Farber Cancer Institute, Boston, MA
- Tian Xu, Yale University School of Medicine, New Haven, CT
What Has GWAS Taught Us About Cancer?
Moderator: Christine B. Ambrosone, Roswell Park Cancer Institute, Buffalo, NY
- David B. Goldstein, Duke University Medical Center, Durham, NC
- Wei Zheng, Vanderbilt University Medical Center, Nashville, TN
What Is the Origin of Serous Ovarian Carcinoma: Surface Epithelium vs. Distal Fallopian Tube?
Moderator: Beth Y. Karlan, Cedars-Sinai Medical Center, Los Angeles, CA
- Ronny I. Drapkin, Dana-Farber Cancer Institute, Boston, MA
- Ernst R. Lengyel, University of Chicago, Chicago, IL
Will Metformin Prevent and/or Cure Cancer?
Moderator: Pamela J. Goodwin, University of Toronto Mount Sinai Hospital, Toronto, ON, Canada
- David Grahame Hardie, College of Life Sciences, Dundee, United Kingdom
- Vuk Stambolic, Ontario Cancer Institute, Princess Margaret Hospital, Toronto, ON, Canada
|